Inventor · disambiguated record
Yinong Xie
Also filed as: XIE YINONG
10 granted patents·4 pending applications·69 citations·filing 2004–2020
87Inventor score
Files withSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD3BUSCH BRETT B2EXELIXIS INC2EXELIXIS PATENT CO LLC2SYNBLIA THERAPEUTICS INC2
Top patents by PatentIndex Score
14 records- 0191US7998995B2LXR and FXR modulatorsEXELIXIS PATENT CO LLC·Filed 2007·Granted Aug 16, 2011·32 cites·45 claims
- 0287US10159662B2Azetidine derivative, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2016·Granted Dec 25, 2018·4 cites·33 claims
- 0386US8703805B2Modulators of LXRBUSCH BRETT B·Filed 2006·Granted Apr 22, 2014·11 cites·41 claims
- 0482US9000022B2Imidazole based LXR modulatorsEXELIXIS PATENT CO LLC·Filed 2013·Granted Apr 7, 2015·6 cites·15 claims
- 0581US10561655B2SHP2 inhibitors and uses thereofSYNBLIA THERAPEUTICS INC·Filed 2019·Granted Feb 18, 2020·6 cites·16 claims
- 0678US8569352B2Imidazole based LXR modulatorsBUSCH BRETT B·Filed 2006·Granted Oct 29, 2013·3 cites·31 claims
- 0774US7482366B2Modulators of LXRX CEPTOR THERAPEUTICS INC·Filed 2004·Granted Jan 27, 2009·7 cites·31 claims
- 0863US11045455B2Azetidine derivative, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Jun 29, 2021·0 cites·15 claims
- 0962US8013001B2Modulators of LXREXELIXIS INC·Filed 2008·Granted Sep 6, 2011·0 cites·34 claims
- 1062US2019060291A1Azetidine derivative, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1153US2008119488A1Modulators Of Nuclear ReceptorsEXELIXIS INC·Filed 2005·Application pending·0 cites
- 1246US9499490B2Fluorophenyl pyrazol compoundsLILLY CO ELI·Filed 2014·Granted Nov 22, 2016·0 cites·13 claims
- 1346US2023010886A1Shp2 inhibitors and uses thereofSUZHOU PUHE BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1433US2020385370A1Apparatus for removing bad odor from toiletSYNBLIA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →